Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters

Bioorg Med Chem Lett. 2015 Jan 15;25(2):245-8. doi: 10.1016/j.bmcl.2014.11.064. Epub 2014 Nov 27.

Abstract

Eight new artemisinin-derived trioxane dimer esters 5 have been prepared and tested for antimalarial efficacy in malaria-infected mice. At a single oral dose of only 6mg/kg combined with 18mg/kg of mefloquine, each of the dimer esters 5 outperformed the antimalarial drug artemether (2). The most efficacious dimer, dichlorobenzoate ester 5h, prolonged mouse survival past day 30 of infection with three of the four mice in this group having no detectable parasitemia and appearing and acting healthy on day 30.

Keywords: Antimalarial chemotherapy; Oral bioavailability; Single oral dose ACT; Trioxane dimer esters.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Animals
  • Antimalarials / administration & dosage*
  • Antimalarials / chemistry*
  • Artemisinins / administration & dosage*
  • Artemisinins / chemistry*
  • Dimerization
  • Malaria / drug therapy*
  • Mice
  • Plasmodium berghei / drug effects*

Substances

  • Antimalarials
  • Artemisinins
  • artemisinin